Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIP Study for prophylaxis in von Willebrand disease
NL-OMON31532Phase 4Recruiting
- Sponsor
- Von Willebrand Disease Prophylaxis Network
- Start
- Oct 2009
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Von Willebrand Disease Prophylaxis Network. Primary endpoints: Bleeding episodes associated with von Willebrand disease, Treatment for breakthrough bleeding and prophylactic dosing and 4 more. Started Oct 2009; status: recruiting.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NL-OMON31532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31532.